Company Filing History:
Years Active: 2022-2024
Title: Marta Katarzyna Westwood: Innovator in Anti-IgE Antibodies
Introduction
Marta Katarzyna Westwood is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of anti-IgE antibodies. With a total of 2 patents, her work focuses on innovative treatments for disorders caused by IgE.
Latest Patents
Westwood's latest patents revolve around improved anti-IgE antibodies and antigen binding agents. These inventions target IgE for use in treating various disorders, including allergic responses and certain autoimmune conditions. Specifically, her work addresses disorders caused by the interaction of IgE with the FcεRI receptor. The improved anti-IgE antibodies may exhibit enhanced affinity for IgE and improved interactions with the Cε2 domain of IgE. Furthermore, these innovations aim to disassociate IgE from the FcεRI receptor at pharmaceutically relevant concentrations, offering novel treatments for IgE-mediated disorders.
Career Highlights
Marta Westwood is associated with Ucbbiopharma Srl, where she continues to advance her research in the field of immunology. Her dedication to improving therapeutic options for patients with IgE-related disorders has positioned her as a key figure in her industry.
Collaborations
Westwood collaborates with notable colleagues, including Ralph Adams and Thomas Allen Ceska. Their combined expertise contributes to the innovative research and development of new therapeutic solutions.
Conclusion
Marta Katarzyna Westwood's contributions to the field of anti-IgE antibodies highlight her role as a leading inventor in biotechnology. Her work promises to enhance treatment options for individuals suffering from IgE-mediated disorders.